257 related articles for article (PubMed ID: 16837811)
21. A prospective observational study of 468 patients undergoing D2 or D3 lymphadenectomy for gastric cancer.
Bostanci EB; Ozer I; Ercan M; Ulas M; Koc U; Karaman K; Dalgic T; Ozogul Y; Akoglu M
Hepatogastroenterology; 2013 May; 60(123):624-7. PubMed ID: 23635437
[TBL] [Abstract][Full Text] [Related]
22. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
23. Radical gastrectomy for gastric cancer at Tata Memorial Hospital.
Bhandare MS; Kumar NAN; Batra S; Chaudhari V; Shrikhande SV
Indian J Cancer; 2017; 54(4):605-608. PubMed ID: 30082543
[TBL] [Abstract][Full Text] [Related]
24. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
25. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.
Sasako M; Sano T; Yamamoto S; Kurokawa Y; Nashimoto A; Kurita A; Hiratsuka M; Tsujinaka T; Kinoshita T; Arai K; Yamamura Y; Okajima K;
N Engl J Med; 2008 Jul; 359(5):453-62. PubMed ID: 18669424
[TBL] [Abstract][Full Text] [Related]
26. A prospective randomized study comparing open versus laparoscopy-assisted D2 radical gastrectomy in advanced gastric cancer.
Cai J; Wei D; Gao CF; Zhang CS; Zhang H; Zhao T
Dig Surg; 2011; 28(5-6):331-7. PubMed ID: 21934308
[TBL] [Abstract][Full Text] [Related]
27. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
28. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors.
Marrelli D; Pedrazzani C; Neri A; Corso G; DeStefano A; Pinto E; Roviello F
Ann Surg Oncol; 2007 Jan; 14(1):25-33. PubMed ID: 17024558
[TBL] [Abstract][Full Text] [Related]
29. Clinical outcome after D1 vs D2-3 gastrectomy for treatment of gastric cancer.
Danielson H; Kokkola A; Kiviluoto T; Sirén J; Louhimo J; Kivilaakso E; Puolakkainen P
Scand J Surg; 2007; 96(1):35-40. PubMed ID: 17461310
[TBL] [Abstract][Full Text] [Related]
30. Extended (D2) lymphadenectomy in gastric cancer: a five year experience.
Pugliese R; Maggioni D; Berardi V; Scandroglio I; Pisani D; Mariani A; Di Lernia S; Valli C; Cocotta E
Int Surg; 2000; 85(3):209-15. PubMed ID: 11324997
[TBL] [Abstract][Full Text] [Related]
31. [Gastrectomy with radical lymphadenectomy--standard therapy of adenocarcinoma of the stomach].
Thybusch A; Schmid A; Henne-Bruns D; Kremer B
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():173-5. PubMed ID: 9101822
[TBL] [Abstract][Full Text] [Related]
32. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial.
Degiuli M; Sasako M; Calgaro M; Garino M; Rebecchi F; Mineccia M; Scaglione D; Andreone D; Ponti A; Calvo F;
Eur J Surg Oncol; 2004 Apr; 30(3):303-8. PubMed ID: 15028313
[TBL] [Abstract][Full Text] [Related]
33. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial.
Songun I; Putter H; Kranenbarg EM; Sasako M; van de Velde CJ
Lancet Oncol; 2010 May; 11(5):439-49. PubMed ID: 20409751
[TBL] [Abstract][Full Text] [Related]
34. [Gastrectomy with radical D2 lymph node excision--effective and economically standardized therapy of adenocarcinoma of the stomach].
Schmid A; Thybusch A; Henne-Bruns D; Kremer B
Langenbecks Arch Chir Suppl Kongressbd; 1997; 114():1066-8. PubMed ID: 9574334
[TBL] [Abstract][Full Text] [Related]
35. [D2 lymph node dissection in gastric cancer surgery: long term results--analysis of an experience with 227 patients].
Vasilescu C; Herlea V; Tidor S; Ivanov B; Stănciulea O; Mănuc M; Gheorghe C; Ionescu M; Diculescu M; Popescu I
Chirurgia (Bucur); 2006; 101(4):375-84. PubMed ID: 17059148
[TBL] [Abstract][Full Text] [Related]
36. Advanced gastric cancer with early cancer macroscopic appearance: is it worthy of D2 lymphadenectomy?
Sun Z; Wang ZN; Zhu GL; Huang BJ; Li K; Xu Y; Li DM; Xu HM
Ann Surg Oncol; 2010 May; 17(5):1278-90. PubMed ID: 20058192
[TBL] [Abstract][Full Text] [Related]
37. Videolaparoscopic total and subtotal gastrectomy with extended lymph node dissection for gastric cancer.
Huscher CG; Mingoli A; Sgarzini G; Sansonetti A; Lirici MM; Napolitano C; Piro F
Am J Surg; 2004 Dec; 188(6):728-35. PubMed ID: 15619491
[TBL] [Abstract][Full Text] [Related]
38. Results of D2 gastrectomy for gastric adenocarcinoma: 10-year experience in Thai patients.
Euanorasetr C; Lertsithichai P
J Med Assoc Thai; 2007 Feb; 90(2):291-300. PubMed ID: 17375634
[TBL] [Abstract][Full Text] [Related]
39. [Analysis of long-term results of radical gastrectomy combining splenectomy for gastric cancer].
Han FH; Zhan WH; Li YM; He YL; Peng JS; Ma JP; Wang Z; Chen ZX; Zheng ZQ; Wang JP; Huang YH; Dong WG
Zhonghua Wai Ke Za Zhi; 2005 Sep; 43(17):1114-7. PubMed ID: 16194307
[TBL] [Abstract][Full Text] [Related]
40. Significance of super-extended (D3) lymphadenectomy in gastric cancer surgery.
Laterza E; Giacopuzzi S; Minicozzi A; Saladino E; de Manzoni G
Ann Ital Chir; 2009; 80(2):101-6. PubMed ID: 19681290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
